David Shultz

3.0k total citations
136 papers, 2.1k citations indexed

About

David Shultz is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, David Shultz has authored 136 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Pulmonary and Respiratory Medicine, 46 papers in Oncology and 35 papers in Genetics. Recurrent topics in David Shultz's work include Brain Metastases and Treatment (45 papers), Glioma Diagnosis and Treatment (35 papers) and Meningioma and schwannoma management (23 papers). David Shultz is often cited by papers focused on Brain Metastases and Treatment (45 papers), Glioma Diagnosis and Treatment (35 papers) and Meningioma and schwannoma management (23 papers). David Shultz collaborates with scholars based in Canada, United States and Netherlands. David Shultz's co-authors include Billy W. Loo, Maximilian Diehn, Alejandro Berlín, Quynh‐Thu Le, Peter G. Maxim, Scott C. Kogan, Fábio Ynoe de Moraes, J. Michael Bishop, Todd A. Aguilera and Daniel L. Rubin and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

David Shultz

126 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Shultz Canada	24	899	547	435	429	356	136	2.1k
Young Kwok United States	24	747 0.8×	587 1.1×	378 0.9×	207 0.5×	253 0.7×	100	2.1k
Jeffrey Meyer United States	23	790 0.9×	621 1.1×	573 1.3×	557 1.3×	249 0.7×	125	2.3k
Eric T. Shinohara United States	27	746 0.8×	731 1.3×	396 0.9×	236 0.6×	765 2.1×	78	2.3k
Mohammad K. Khan United States	30	970 1.1×	1.0k 1.9×	175 0.4×	558 1.3×	432 1.2×	121	2.5k
Deirdre Jill Cohen United States	23	436 0.5×	741 1.4×	334 0.8×	235 0.5×	327 0.9×	96	1.7k
Pramod Kumar Julka India	22	478 0.5×	326 0.6×	411 0.9×	340 0.8×	341 1.0×	124	1.6k
Kaitlin M. Woo United States	29	1.2k 1.3×	1.3k 2.5×	302 0.7×	415 1.0×	404 1.1×	66	2.7k
John T. Lucas United States	24	843 0.9×	347 0.6×	421 1.0×	219 0.5×	247 0.7×	123	2.2k
Michela Buglione Italy	23	988 1.1×	654 1.2×	431 1.0×	407 0.9×	279 0.8×	121	2.1k
Pierluigi Bonomo Italy	26	1.1k 1.2×	864 1.6×	668 1.5×	751 1.8×	200 0.6×	172	2.7k

Countries citing papers authored by David Shultz

Since Specialization

Citations

This map shows the geographic impact of David Shultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Shultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Shultz more than expected).

Fields of papers citing papers by David Shultz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Shultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Shultz. The network helps show where David Shultz may publish in the future.

Co-authorship network of co-authors of David Shultz

This figure shows the co-authorship network connecting the top 25 collaborators of David Shultz. A scholar is included among the top collaborators of David Shultz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Shultz. David Shultz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Griffin, Anthony M., Charles Catton, Peter Chung, et al.. (2025). Outcomes of local therapies for recurrent and radiation-associated soft tissue sarcomas of the extremities and trunk: is there a role for re-irradiation?. Radiotherapy and Oncology. 212. 111136–111136.

Laperrière, Normand, Tatiana Conrad, Barbara‐Ann Millar, et al.. (2024). Surgical Resection Followed by Stereotactic Radiosurgery (S+SRS) Versus SRS Alone for Large Posterior Fossa Brain Metastases: A Comparative Analysis of Outcomes and Factors Guiding Treatment Modality Selection. Brain Sciences. 14(11). 1059–1059. 2 indexed citations

Griffin, Andrew S., Amy Parent, Brendan O’Sullivan, et al.. (2024). Reduction of Bone Fracture after Radiotherapy in Lower Extremity Soft Tissue Sarcoma after Implementing Bone Avoidance Objectives for Radiotherapy Planning. International Journal of Radiation Oncology*Biology*Physics. 120(2). S89–S89. 2 indexed citations

Kalyvas, Aristotelis, Kaiyun Yang, Barbara‐Ann Millar, et al.. (2024). Rate of pachymeningeal failure following adjuvant WBRT vs SRS in patients with brain metastases. Clinical and Translational Radiation Oncology. 45. 100723–100723.

Abbas‐Aghababazadeh, Farnoosh, et al.. (2024). Radiomic-based prediction of lesion-specific systemic treatment response in metastatic disease. Computerized Medical Imaging and Graphics. 116. 102413–102413.

Wunder, Jay S., Peter C. Ferguson, Kim M. Tsoi, et al.. (2023). Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC study. Therapeutic Advances in Medical Oncology. 15. 2643679–2643679. 3 indexed citations

Li, Winnie, David Shultz, Normand Laperrière, et al.. (2023). Assessment of intra-fraction motion during frameless image guided Gamma Knife stereotactic radiosurgery. Physics and Imaging in Radiation Oncology. 25. 100415–100415.

Abbas‐Aghababazadeh, Farnoosh, et al.. (2023). Radiomic-Based Prediction of Lesion-Specific Systemic Treatment Response in Metastatic Disease. International Journal of Radiation Oncology*Biology*Physics. 117(2). e466–e467. 1 indexed citations

Parent, Amy, Harley Chan, Normand Laperrière, et al.. (2023). A total inverse planning paradigm: Prospective clinical trial evaluating the performance of a novel MR-based 3D-printed head immobilization device. Clinical and Translational Radiation Oncology. 42. 100663–100663. 1 indexed citations

10.

Ng, Deanna, David P. Cyr, Dario Callegaro, et al.. (2022). Effect of Preoperative Treatment on the Performance of Predictive Nomograms in Primary Retroperitoneal Sarcoma. Annals of Surgical Oncology. 29(4). 2304–2314. 4 indexed citations

11.

Shultz, David, et al.. (2022). Radiomics in sarcoma trials: a complement to RECIST for patient assessment. Journal of Cancer Metastasis and Treatment. 8. 45–45. 1 indexed citations

12.

Shultz, David, et al.. (2022). Bevacizumab for Cerebral Radionecrosis: A Single-Center Experience. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50(4). 573–578. 7 indexed citations

13.

Li, Winnie, Angela Cashell, Catherine Coolens, et al.. (2020). Patient perspectives on frame versus mask immobilization for gamma knife stereotactic radiosurgery. Journal of medical imaging and radiation sciences. 51(4). 567–573. 5 indexed citations

14.

Kuo, Peiwen, Scott V. Bratman, David Shultz, et al.. (2014). Galectin-1 Mediates Radiation-Related Lymphopenia and Attenuates NSCLC Radiation Response. Clinical Cancer Research. 20(21). 5558–5569. 54 indexed citations

15.

Shultz, David, J.C. Grecula, James A. Hayman, Maximilian Diehn, & Billy W. Loo. (2013). The Optimal Use of Radiotherapy in Small Cell Lung Cancer. Journal of the National Comprehensive Cancer Network. 11(1). 107–114. 1 indexed citations

16.

Shultz, David, M.R. Sandhya Rani, John Fuller, Richard M. Ransohoff, & George R. Stark. (2009). Roles of IKK-β, IRF1, and p65 in the Activation of Chemokine Genes by Interferon-γ. Journal of Interferon & Cytokine Research. 29(12). 817–824. 39 indexed citations

17.

Shultz, David, John Fuller, Yonghui Yang, et al.. (2007). Activation of a Subset of Genes by IFN- γ Requires IKK β but Not Interferon-Dependent Activation of NF- κ B. Journal of Interferon & Cytokine Research. 27(10). 875–884. 16 indexed citations

18.

Liu, Bin, Yonghui Yang, Rachel R. Ogorzalek Loo, et al.. (2007). Proinflammatory Stimuli Induce IKKα-Mediated Phosphorylation of PIAS1 to Restrict Inflammation and Immunity. Cell. 129(5). 903–914. 130 indexed citations

19.

Sizemore, Nywana, Anju Agarwal, Kingshuk Das, et al.. (2004). Inhibitor of κB kinase is required to activate a subset of interferon γ-stimulated genes. Proceedings of the National Academy of Sciences. 101(21). 7994–7998. 49 indexed citations

20.

Phan, Vernon T., David Shultz, Timothy J. Blake, et al.. (2003). Cooperation of Cytokine Signaling with Chimeric Transcription Factors in Leukemogenesis: PML-Retinoic Acid Receptor Alpha Blocks Growth Factor-Mediated Differentiation. Molecular and Cellular Biology. 23(13). 4573–4585. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact